Liberty Biotek aims to develop the first FDA approved generic formulation of an antiseptic solution for ophthalmic use. The reference listed drug is no longer protected by any unexpired patents or regulatory exclusivity per the FDA Orange Book. The development would qualify for a regulatory biowaiver, which allows equivalence to be shown without in vivo testing data.